Night time symptom control with omnic (tamsulosin) oral controlled absorption system (OCAS®)

被引:5
作者
Chapple, CR [1 ]
机构
[1] Royal Hallamshire Hosp, Dept Urol, Sheffield Teaching Hosp, NHS Trust, Sheffield S10 2JF, S Yorkshire, England
关键词
tamsulosin; oral controlled absorption system; nocturia; sleep; quality of life; hours of undisturbed sleep;
D O I
10.1016/j.eursup.2005.07.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:14 / 16
页数:3
相关论文
共 13 条
[1]   Nocturia: the major problem in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (LUTS/BPO) [J].
Abrams, P .
EUROPEAN UROLOGY SUPPLEMENTS, 2005, 3 (06) :8-16
[2]   Nocturia: the effect on sleep and related health consequences [J].
Abrams, P .
EUROPEAN UROLOGY SUPPLEMENTS, 2005, 3 (06) :1-7
[3]   Nocturia: consequences for sleep and daytime activities and associated risks [J].
Asplund, R .
EUROPEAN UROLOGY SUPPLEMENTS, 2005, 3 (06) :24-32
[4]   THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
OLEARY, MP ;
BRUSKEWITZ, RC ;
HOLTGREWE, HL ;
MEBUST, WK ;
COCKETT, ATK ;
BLAIVAS, JG ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1992, 148 (05) :1549-1557
[5]   The development of the oral controlled absorption system (OCAS®):: A new improved formulation of tamsulosin [J].
Chapple, CR .
EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (07) :1-4
[6]   Tamsulosin oral controlled absorption system (OCAS) in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH):: Efficacy and tolerability in a placebo and active comparator controlled phase 3a study [J].
Chapple, CR ;
Al-Shukri, SH ;
Gattegno, B ;
Holmes, S ;
Martínez-Sagarra, JM ;
Scarpa, RM ;
Trip, OBV ;
Vik, V ;
van der Putten-Slob, I .
EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (02) :33-44
[7]   The impact of tamsulosin oral controlled absorption system (OCAS) on nocturia and the quality of sleep: Preliminary results of a pilot study [J].
Djavan, B ;
Milani, S ;
Davies, J ;
Bolodeoku, J .
EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (02) :61-68
[8]   State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia [J].
Djavan, B ;
Chapple, C ;
Milani, S ;
Marberger, M .
UROLOGY, 2004, 64 (06) :1081-1088
[9]   The pharmacokinetic profile of tamsulosin oral controlled absorption system (OCAS®) [J].
Michel, MC ;
Korstanje, C ;
Krauwinkel, W ;
Kuipers, M .
EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (02) :15-24
[10]   Influence of physical factors in gastrointestinal tract on acetaminophen release from controlled-release tablets in fasted dogs [J].
Sako, K ;
Mizumoto, T ;
Kajiyama, A ;
Ohmura, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 137 (02) :225-232